A sneak peak at the topic to come: Digital trade in services is one of the most dynamic sectors in the global economy. The International Chamber of Commerce (ICC) has tasked you to review regulatory practices in (Region/Country X) for the digital economy and identify measures to facilitate and support digital trade.
AboutUs We are a global advisory firm known for their ability to respond to global challenges rapidly and incisively. We use the most advanced tools and technology and combine them with our team of leading international experts to engage decision-makers in tackling society’s most significant challenges. We are recognized for our rapid decision support, innovation, data science algorithms and deep policy expertise. We are specialists in “connecting the dots” between policy, business and enhancing the lives of citizens
This content was provided by an external organisation and does not necessarily represent the views of the University of Cambridge Careers Service. We cannot accept responsibility for errors or inaccuracies in this content.
Our ambition is to discover transformative breakthroughs that hold a key to transforming the treatment of some of the world’s most complex diseases. We’re now opening applications for our second R&D Postdoctoral Challenge, inviting final year MD and/or PhD students and Postdoctoral Researchers to propose their own innovative ideas to accelerate drug discovery and development. Shortlisted applicants will have the opportunity to pitch their research proposals to a world-leading judging panel with the potential to be awarded a fully funded postdoctoral position at AstraZeneca.
In 2022 we received submissions from almost 40 countries to the R&D Postdoctoral Challenge. Following a tough final event, our judges unanimously agreed to award fully funded postdoctoral research positions to each of our six finalists.
What are we looking for?
We are seeking proposals from outstanding final year MD and/or PhD students or Postdoctoral Researchers within three years of receiving their advance postgraduate degree (MD and/or PhD) by 31 December 2023. Candidates may be based anywhere in the world and have an innovative idea that could push the boundaries of science, in our focus areas of cardiovascular, renal & metabolic diseases, respiratory & immunology, common infectious and rare diseases. We are also interested in new innovative technologies to improve development of novel therapeutics and treatment approaches. Proposals will be critiqued based on scientific merit, and opportunity to create real impact for patients, society and business.
Benefits
Successful candidates will be awarded a fully funded postdoctoral position, join our vibrant scientific community, and will have access to expertise, compounds, novel tools and technologies, and the mentoring support they need to turn their ideas into reality. They will access a world of learning opportunities, building the foundations of their professional networks that could last a lifetime.
Successful candidates will have the opportunity to conduct their research at one of our leading R&D facilities for two years (with an option for a third year) to pursue and develop the creative research ideas they propose – fully funded by AstraZeneca. They will be surrounded by a diverse group of amazing scientists, with the chance to challenge each other – and grow and develop together.
Academic and AstraZeneca mentors will support and coach successful candidates to develop their skills, and support them in learning new approaches, plus the support to rapidly learn new approaches to follow the science, innovate and make an impact. They will regularly present at internal monthly seminars and our annual workshop, and also attend external scientific conferences and seminars to present their work, eventually leading to quality publications in leading journals.
Who are we looking for?
We are looking for passionate individuals in their final year of graduate studies (MD and/or PhD), or working as a Postdoctoral Researcher within three years of receiving their advance postgraduate degree (MD and/or PhD) by 31 December 2023, regardless of age.
Candidates must be keen to undertake pioneering R&D focused on preventing, modifying, and potentially curing disease for some of the world’s most complex diseases, proposing innovative ideas that align with our therapy areas – cardiovascular, renal & metabolic diseases, respiratory & immunology, rare disease – and/or our transformative science themes:
Enhancing our understanding of disease biology
Creating the next generation of therapeutics
Better predicting clinical success
Pioneering new approaches to engagement in the clinic and beyond
Postdoctoral Researchers need to be able to make a reasonable amount of scientific progress on their idea within the 2-3 year Postdoctorate time frame.
This content was provided by an external organisation and does not necessarily represent the views of the University of Cambridge Careers Service. We cannot accept responsibility for errors or inaccuracies in this content.
Silver Lake is a global technology investing firm with 20+ years of history making notable investments in market-leading franchises—such as Alibaba, Dell Technologies, GoDaddy, Celonis, Skype, Airbnb, and Twitter —in partnership with world-class management teams.
Silver Lake originally launched its Distinguished Scholars Program in 2020 for U.S. university students, and is delighted to now announce the inaugural London Distinguished Scholars Program for European university students. The program is a virtual year-long curriculum targeting high-achieving female students who wish to learn about private equity investing at a leading global investment firm. Silver Lake will be admitting 6-8 Distinguished Scholars across top- tier universities in Europe to learn about Silver Lake and private equity from our full-time professionals. The 2023-24 programme will feature quarterly virtual sessions over zoom and a multi-day live component taking place towards the end of the summer / beginning of autumn hosted in our London office. Distinguished Scholars will gain insights to our firm’s business, industry, and culture and receive training and direct mentorship from our investment team and other professionals. Exceptional Distinguished Scholars will come out of this program with a unique and differentiated experience and may be considered for a future full-time position with the firm.
Who Can Apply
The Distinguished Scholar role is open to female candidates currently pursuing a bachelor’s degree or master’s degree in their final year (i.e. graduating in Winter 2023 through Summer 2024). We are looking for students with an outstanding record of academic and professional achievement and a strong interest in businesses and financial markets. We value diversity of thought, backgrounds, experiences, and perspectives and are looking for motivated, resourceful, analytical people with exceptional interpersonal and communication skills who enjoy tackling new challenges and solving intellectual problems.
The application deadline is 29th May.
Program Logistics
An in-person “Private Equity” Bootcamp towards the end of the summer / beginning of autumn 2023, with the program expected to last through the end of summer 2024.
The Distinguished Scholars will receive travel & accommodations for the in-person portion of the program.
Further detail on the program and application requirements can be found via the application portal here.
This content was provided by an external organisation and does not necessarily represent the views of the University of Cambridge Careers Service. We cannot accept responsibility for errors or inaccuracies in this content.
